Medicine
Ampicillin 500 mg capsule
Ampicillin 500 mg capsule is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Ampicillin
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 28 capsules and 2 more
- Manufacturers
- Aurobindo PharmaIndiaSandozRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CA01 Ampicillin
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 August 1995
- Identifiers
- RxCUI 308212, 313800DailyMed set ID 0a66c5c3-63bf-46e3-835e-26b555ab6954, 4134cd79-c895-4e6e-b1d5-8e01c38bf2d1, 7f8b1ab1-73c6-4cdf-a838-7a4554c62586NDC 0781-2145, 70518-2607, 59651-551Application ANDA064082, ANDA216554
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 59651-551-01 | Aurobindo PharmaIndia | 31 October 2023 |
| 500 capsule in 1 bottle | 59651-551-05 | Aurobindo PharmaIndia | 31 October 2023 |
| 100 capsule in 1 bottle | 0781-2145-01 | Sandoz | 29 August 1995 |
| 500 capsule in 1 bottle | 0781-2145-05 | Sandoz | 29 August 1995 |
| 28 capsule in 1 bottle, plastic | 70518-2607-1 | Remedyrepack | 17 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1966 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ampicillin
Clinical summary
Ampicillin is a penicillin-class antibacterial indicated in the treatment of infections caused by susceptible strains of the designated organisms in conditions. It is available as powder for injection and capsules for intravenous, intramuscular and oral use. MedsAcross supplies Ampicillin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AmpicillinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ampicillin prescribing information (NorthStar Rx) · U.S. National Library of Medicine, DailyMed
Need Ampicillin 500 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.